Patricia Shaw

Targeted DNA Methylation Screen in the Mouse Mammary Genome Reveals a Parity-Induced Hypermethylation of Igf1r That Persists Long after Parturition.

Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.

High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer.

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.

Incidental MRI detection of BRCA1-related solitary peritoneal carcinoma during breast screening--A case report.

Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer.

A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers.

Interstitial permeability and elasticity in human cervix cancer.

"Pagetoid" eccrine carcinoma of the vulva: report of an unusual case with review of the literature.

Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma.

A content analysis of the quantity and accuracy of dietary supplement information found in magazines with high adolescent readership.

Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.

Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary.

Solitary fibrous tumor of the uterine cervix.

International network of cancer genome projects.

Risk factors for non-invasive lesions of the fallopian tube in BRCA mutation carriers.

Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs).

Decreased progesterone receptor isoform expression in luteal phase fallopian tube epithelium and high-grade serous carcinoma.

Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.

Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells.

In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry.

Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.

Identification of abrogated pathways in fallopian tube epithelium from BRCA1 mutation carriers.

Letter to the editor regarding 'Roh MH, Lassin Y, Miron A et al. High-grade fimbrial-ovarian carcinomas are unified by p53, PTEN and PAX2 expression'.

Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study.

Noninvasive prenatal diagnosis of a fetal microdeletion syndrome.

Cancer genomics: technology, discovery, and translation.

Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma.

Prolonged postovulatory proinflammatory signaling in the fallopian tube epithelium may be mediated through a BRCA1/DAB2 axis.

Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.

Endometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors.

Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.

Feasibility of real time next generation sequencing of cancer genes linked to drug response: results from a clinical trial.

Proliferation in the normal FTE is a hallmark of the follicular phase, not BRCA mutation status.

Cancer classification using the Immunoscore: a worldwide task force.

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.

Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2.

Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma.

Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.

Overlapping structures in sensory-motor mappings.

High resolution non-invasive detection of a fetal microdeletion using the GCREM algorithm.

BRCA and Early Events in the Development of Serous Ovarian Cancer.

Specimen quality evaluation in Canadian biobanks participating in the COEUR repository.

The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.

Comprehensive analysis of preeclampsia-associated DNA methylation in the placenta.

The role of KIF14 in patient-derived primary cultures of high-grade serous ovarian cancer cells.

Cancer precursor lesions in the BRCA population at the time of prophylactic salpingo-oophorectomy: Accuracy of assessment and potential surrogate marker for prevention.